BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31366581)

  • 21. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth.
    Cha TL; Qiu L; Chen CT; Wen Y; Hung MC
    Cancer Res; 2005 Mar; 65(6):2287-95. PubMed ID: 15781642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
    Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K
    BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer.
    Kim Y; Kim J; Jang SW; Ko J
    Oncogene; 2015 Jan; 34(2):226-36. PubMed ID: 24441043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen receptor regulates expression of the MUC1-C oncoprotein in human prostate cancer cells.
    Rajabi H; Joshi MD; Jin C; Ahmad R; Kufe D
    Prostate; 2011 Sep; 71(12):1299-308. PubMed ID: 21308711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
    Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
    J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.
    Tan JA; Bai S; Grossman G; Titus MA; Harris Ford O; Pop EA; Smith GJ; Mohler JL; Wilson EM; French FS
    Mol Cell Endocrinol; 2014 Jan; 382(1):302-313. PubMed ID: 24103312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer cells tolerate a narrow range of androgen receptor expression and activity.
    Tararova ND; Narizhneva N; Krivokrisenko V; Gudkov AV; Gurova KV
    Prostate; 2007 Dec; 67(16):1801-15. PubMed ID: 17935158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.
    Hååg P; Bektic J; Bartsch G; Klocker H; Eder IE
    J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):251-8. PubMed ID: 15982869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha.
    Ko S; Shi L; Kim S; Song CS; Chatterjee B
    Mol Endocrinol; 2008 Feb; 22(2):273-86. PubMed ID: 17975021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity.
    Vummidi Giridhar P; Williams K; VonHandorf AP; Deford PL; Kasper S
    Cancer Res; 2019 Mar; 79(6):1124-1137. PubMed ID: 30626627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.
    Daniels G; Li Y; Gellert LL; Zhou A; Melamed J; Wu X; Zhang X; Zhang D; Meruelo D; Logan SK; Basch R; Lee P
    Endocr Relat Cancer; 2014 Feb; 21(1):127-42. PubMed ID: 24243687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer.
    McClurg UL; Harle VJ; Nabbi A; Batalha-Pereira A; Walker S; Coffey K; Gaughan L; McCracken SR; Robson CN
    Oncotarget; 2015 Nov; 6(35):37724-36. PubMed ID: 26462181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival.
    Wang Y; Mikhailova M; Bose S; Pan CX; deVere White RW; Ghosh PM
    Oncogene; 2008 Nov; 27(56):7106-17. PubMed ID: 18776922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic role of PinX1 in prostate cancer cells through androgen receptor dependent and independent mechanisms.
    Flores-Ramírez I; Rivas-Torres MÁ; Rodríguez-Dorantes M; Gutiérrez-Sagal R; Baranda-Avila N; Langley E
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105858. PubMed ID: 33647521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.
    Bishop JL; Thaper D; Vahid S; Davies A; Ketola K; Kuruma H; Jama R; Nip KM; Angeles A; Johnson F; Wyatt AW; Fazli L; Gleave ME; Lin D; Rubin MA; Collins CC; Wang Y; Beltran H; Zoubeidi A
    Cancer Discov; 2017 Jan; 7(1):54-71. PubMed ID: 27784708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells.
    Lin HP; Lin CY; Hsiao PH; Wang HD; Jiang SS; Hsu JM; Jim WT; Chen M; Kung HJ; Chuu CP
    PLoS One; 2013; 8(12):e82625. PubMed ID: 24349321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells.
    Rajabi H; Ahmad R; Jin C; Joshi MD; Guha M; Alam M; Kharbanda S; Kufe D
    Prostate; 2012 Nov; 72(15):1659-68. PubMed ID: 22473899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXM1 and androgen receptor co-regulate CDC6 gene transcription and DNA replication in prostate cancer cells.
    Liu Y; Gong Z; Sun L; Li X
    Biochim Biophys Acta; 2014; 1839(4):297-305. PubMed ID: 24583551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deubiquitinating enzyme Usp12 is a novel co-activator of the androgen receptor.
    Burska UL; Harle VJ; Coffey K; Darby S; Ramsey H; O'Neill D; Logan IR; Gaughan L; Robson CN
    J Biol Chem; 2013 Nov; 288(45):32641-32650. PubMed ID: 24056413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EBP1 inhibits translation of androgen receptor mRNA in castration resistant prostate cancer cells.
    Zhou H; Zhang Y; Hamburger AW
    Anticancer Res; 2011 Oct; 31(10):3129-35. PubMed ID: 21965718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.